8UY1 image
Entry Detail
PDB ID:
8UY1
Keywords:
Title:
Methylenetetrahydrofolate reductase from Chaetomium thermophilum DSM 1495, Active (R) State
Biological Source:
PDB Version:
Deposition Date:
2023-11-12
Release Date:
2024-06-19
Method Details:
Experimental Method:
Resolution:
3.49 Å
R-Value Free:
0.25
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Methylenetetrahydrofolate reductase-like protein
Mutations:E21Q,L393M,V516F
Chain IDs:A (auth: D), B (auth: A), C (auth: B), D (auth: C)
Chain Length:617
Number of Molecules:4
Biological Source:Thermochaetoides thermophila DSM 1495
Ligand Molecules
Primary Citation
Structural basis of S-adenosylmethionine-dependent allosteric transition from active to inactive states in methylenetetrahydrofolate reductase.
Nat Commun 15 5167 5167 (2024)
PMID: 38886362 DOI: 10.1038/s41467-024-49327-5

Abstact

Methylenetetrahydrofolate reductase (MTHFR) is a pivotal flavoprotein connecting the folate and methionine methyl cycles, catalyzing the conversion of methylenetetrahydrofolate to methyltetrahydrofolate. Human MTHFR (hMTHFR) undergoes elaborate allosteric regulation involving protein phosphorylation and S-adenosylmethionine (AdoMet)-dependent inhibition, though other factors such as subunit orientation and FAD status remain understudied due to the lack of a functional structural model. Here, we report crystal structures of Chaetomium thermophilum MTHFR (cMTHFR) in both active (R) and inhibited (T) states. We reveal FAD occlusion by Tyr361 in the T-state, which prevents substrate interaction. Remarkably, the inhibited form of cMTHFR accommodates two AdoMet molecules per subunit. In addition, we conducted a detailed investigation of the phosphorylation sites in hMTHFR, three of which were previously unidentified. Based on the structural framework provided by our cMTHFR model, we propose a possible mechanism to explain the allosteric structural transition of MTHFR, including the impact of phosphorylation on AdoMet-dependent inhibition.

Legend

Protein

Chemical

Disease

Primary Citation of related structures